VEGFA, PLAU, MMP2, MMP9, and MMP14 expression levels were reduced by stigmasterol treatment, which exerted a complex anticancer effect in the context of ovarian cancer [48]. The gene discussed is PLAU; the disease is ovarian carcinoma.